PPL
54
2
JWN
40
-2
LB
34
8
C
58
-2
NRG
49
-3
EW
37
-2
WMT
74
2
PRU
57
-3
HRB
51
2
DE
46
3
UPS
41
-4
NWL
44
-4
DHI
48
3
AES
39
-4
AZO
46
-3
LLY
39
9
MCO
73
3
IP
70
2
NTAP
64
2
MDLZ
34
2
PPL
54
2
JWN
40
-2
LB
34
8
C
58
-2
NRG
49
-3
EW
37
-2
WMT
74
2
PRU
57
-3
HRB
51
2
DE
46
3
UPS
41
-4
NWL
44
-4
DHI
48
3
AES
39
-4
AZO
46
-3
LLY
39
9
MCO
73
3
IP
70
2
NTAP
64
2
MDLZ
34
2
Financhill
Back

Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36

APLS
Apellis Pharmaceuticals

Last Price:
27.45
Seasonality Move:
16.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Apellis Pharmaceuticals Price Quote

$27.45
-0.04 (-0.15%)
(Updated: November 21, 2024 at 1:50 PM ET)

Apellis Pharmaceuticals Key Stats

Sell
36
Apellis Pharmaceuticals (APLS) is a Sell
Day range:
$27.38 - $28.98
52-week range:
$24.34 - $73.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.51
P/B ratio:
13.73%
Volume:
3.3M
Avg. volume:
3.6M
1-year change:
-44.46%
Market cap:
$3.3B
Revenue:
$396.6M
EPS:
$-2.03

How Much Does Apellis Pharmaceuticals Make?

Is Apellis Pharmaceuticals Growing As A Company?

Apellis Pharmaceuticals Stock Price Performance

What Is Apellis Pharmaceuticals 52-Week High & Low?

Apellis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Apellis Pharmaceuticals?

Is Apellis Pharmaceuticals Cash Flow Positive?

  • What Is APLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$205.1M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $149.3M
  • What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$379K

Apellis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    APLS return on invested capital is -52.47%
  • What Is Apellis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -29.46%
  • What Is APLS Return On Equity?
    ROE is a measure of profitability and is -104.65%

Apellis Pharmaceuticals Earnings Date & Stock Price

Apellis Pharmaceuticals Competitors

Apellis Pharmaceuticals Dividend Yield

Apellis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -71.42%
Revenue: 78.29% -1.5%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 46.79
Upside from Last Price: 70.21%

Major Shareholders

  • How many APLS shares are owned by institutional investors?
    192M APLS shares are owned by institutional investors
  • How many APLS shares are owned by insiders?
    3.8M APLS shares are owned by insiders